Effectiveness of intensive smoking reduction counselling plus combination nicotine replacement therapy in promoting long-term abstinence in patients with chronic obstructive pulmonary disease not ready to quit smoking: Protocol of the REDUQ trial

Contemporary Clinical Trials Communications

Volumn 8, Issue , 2017, Pages 248-257

  Hagens, Petra ^a   Pieterse, Marcel ^a   van der Valk, Paul ^b   van der Palen, Job ^a,b  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

Chronic obstructive pulmonary disease; Intervention; Nicotine replacement therapy; Randomised controlled trial; Smoking cessation; Smoking reduction

Indexed keywords

COTININE;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; ATTITUDE TO HEALTH; BEHAVIOR CHANGE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; COGNITION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEPRESSION; FOLLOW UP; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; INCIDENCE; INTENSIVE CARE; LONG TERM CARE; LUNG FUNCTION; MINDFULNESS; MOTIVATION; MOTIVATIONAL INTERVIEWING; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PATIENT COUNSELING; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF HELP; SMOKING CESSATION; SMOKING CESSATION PROGRAM; SMOKING REDUCTION COUNSELLING; SOCIAL ASPECT; TREATMENT DURATION; WITHDRAWAL SYNDROME;

EID: 85034025355     PISSN: 24518654     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.conctc.2017.08.014     Document Type: Article

References (54)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD), Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease - 2016. Available from http://goldcopd.org/.
2. Pauwels, R.A., Rabe, K.F., Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364:9434 (2004), 613–620, 10.1016/S0140-6736(04)16855-4.
3. Anthonisen, N.R., Connett, J.E., Kiley, J.P., Altose, M.D., Bailey, W.C., Buist, A.S., O'Hara, P., Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. J. Am. Med. Assoc. 272 (1994), 1497–1505, 10.1001/jama.1994.03520190043033.
4. Fletcher, C.M., The Natural History of Chronic Bronchitis and Emphysema: an Eight Year Study of Early Chronic Obstructive Lung Disease in Working Men in London. 1976, Oxford University Press, New York.
5. Pelkonen, M., Notkola, I.-L., Tukiainen, H., Tervahauta, M., Tuomilehto, J., Nissinen, A., Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the seven countries study. Thorax 56:9 (2001), 703–707, 10.1136/thorax.56.9.703.
6. Au, D.H., Bryson, C.L., Chien, J.W., Sun, H., Udris, E.M., Evans, L.E., Bradley, K.A., The effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbations. J. Gen. Intern. Med. 24:4 (2009), 457–463, 10.1007/s11606-009-0907-y.
7. Anthonisen, N.R., Skeans, M.A., Wise, R.A., Manfreda, J., Kanner, R.E., Connett, J.E., The effects of a smoking cessation intervention on 14.5 year mortality: a randomized clinical trial. Ann. Intern Med. 142:4 (2005), 233–239, 10.7326/0003-4819-142-4-200502150-00005.
8. Hilberink, S.R., Jacobs, J.E., Schlosser, M., Grol, R.P., De Vries, H., Characteristics of patients with COPD in three motivational stages related to smoking cessation. Patient Educ. Couns. 61:3 (2006), 449–457, 10.1016/j.pec.2005.05.012.
9. Schiller, J.S., Ni, H., Cigarette smoking and smoking cessation among persons with chronic obstructive pulmonary disease. Am. J. Health Promot. 20:5 (2006), 319–323, 10.4278/0890-1171-20.5.319.
10. Tashkin, D.P., Murray, R.P., Smoking cessation in chronic obstructive pulmonary disease. Resp. Med. 103:7 (2009), 963–974, 10.1016/j.rmed.2009.02.013.
11. Tønnesen, P., Smoking cessation and COPD. Eur. Respir. Rev. 22:127 (2013), 37–43, 10.1183/09059180.00007212.
12. Vozoris, N.T., Stanbrook, M.B., Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Resp. Med. 105:3 (2011), 477–484, 10.1016/j.rmed.2010.08.011.
13. DiClemente, C.C., Prochaska, J.O., Fairhurst, S.K., Velicer, W.F., Velasquez, M.M., Rossi, J.S., The process of smoking cessation: an analysis of precontemplation, contemplation and preparation stages of change. J. Consult. Clin. Psychol. 59:2 (1991), 295–304, 10.1037/0022-006X.59.2.295.
14. Dijkstra, A., Roijackers, J., De Vries, H., Smokers in four stages of readiness to change. Addict. Behav. 23:3 (1998), 339–350, 10.1016/S0306-4603(97)00070-1.
15. Prochaska, J.O., DiClemente, C.C., Stages and processes of self-change of smoking: toward an integrative model of change. J. Consult. Clin. Psychol. 51:3 (1983), 390–395, 10.1037/0022-006X.
16. Prochaska, J.O., Velicer, W.F., DiClemente, C.C., Measuring processes of change: applications to the cessation of smoking. J. Consult. Clin. Psychol. 56:4 (1988), 520–528, 10.1037//0022-006X.56.4.520.
17. Hilberink, S.R., Jacobs, J.E., Schlosser, M., Grol, R.P., De Vries, H., Characteristics of patients with COPD in three motivational stages related to smoking cessation. Patient Educ. Couns. 61:3 (2006), 449–457, 10.1016/j.pec.2005.05.012.
18. Asfar, T., Ebbert, J.O., Klesges, R.C., Relyea, G.E., Do smoking reduction interventions promote cessation in smokers not ready to quit?. Addict. Behav. 36:7 (2011), 764–768, 10.1016/j.addbeh.2011.02.003.
19. Fagerstrom, K., Smoking reduction in the management of COPD. Monaldi Arch. Chest. Dis. 57:5–6 (2002), 281–284.
20. Heatherton, T.F., Kozlowski, L.T., Frecker, R.C., Fagerström, K.O., The fagerstrom test for nicotine dependence: a revision of the fagerström tolerance questionnaire. Br. J. Addict. 86:9 (1991), 1119–1127, 10.1111/j.13600443.1991.tb01879.x.
21. De Vries, H., Dijkstra, M., Kuhlman, P., Self-efficacy: the third factor besides attitude and subjective norm as a predictor of behavioural intentions. Health Educ. Res. 3 (1988), 273–282, 10.1093/her/3.3.273.
22. De Vries, H., Mudde, A.N., Predicting stage transitions for smoking cessation applying the attitude-social influence-efficacy model. Psychol. Health 13 (1998), 369–385, 10.1080/08870449808406757.
23. De Vries, H., Mudde, A., Leijs, I., Charlton, A., Vartiainen, E., Buijs, G., Kremers, S., The European Smoking prevention Framework Approach (EFSA): an example of integral prevention. Health Educ. Res. 18:5 (2003), 611–626, 10.1093/her/cyg031.
24. De Vries, H., Mesters, I., Van de Steeg, H., Honing, C., The general public's information needs and perceptions regarding hereditary cancer: an application of the integrated change model. Patient Educ. Couns. 56:2 (2005), 154–165, 10.1016/j.pec.2004.01.002.
25. Hofmann, S.G., Asnaani, A., Vonk, I.J.J., Sawyer, A.T., Fang, A., The efficacy of cognitive behavioral therapy: a review of meta-analyses. Cogn. Ther. Res. 36:5 (2012), 427–440, 10.1007/s10608-012-9476-1.
26. Marlatt, G.A., Gordon, J.R.E., Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. 1985, Guilford Press, New York.
27. Bowen, S., Chawla, N., Marlatt, G.A., Mindfulness-based Relapse Prevention for the Treatment of Substance Use Disorders: a Clinician's Guide. 2010, Guilford Press, New York, NY.
28. Miller, W.R., Rollnick, S., Motivational Interviewing: Preparing People to Change. 2002, The Guilford Press, New York.
29. Cinciripini, P.M., Lapitsky, L.G., Wallfisch, A., Mace, R., Nezami, E., Van Vunakis, H., An evaluation of a multicomponent treatment program involving scheduled smoking and relapse prevention procedures: initial findings. Addict. Behav. 19:1 (1994), 13–22, 10.1016/0306-4603(94)90047-7.
30. Cinciripini, P.M., Lapitsky, L., Seay, S., Wallfisch, A., Kitchens, K., Van Vunakis, H., The effects of smoking schedules on cessation outcome: can we improve on common methods of gradual and abrupt nicotine withdrawal?. J. Consult. Clin. Psychol. 63:3 (1995), 388–399.
31. Cinciripini, P.M., Wetter, D.W., McClure, J.B., Scheduled reduced smoking: effects on smoking abstinence and potential mechanisms of action. Addict. Behav. 22:6 (1997), 759–767, 10.1016/S0306-4603(97)00061-0.
32. Christenhusz, L.C.A., Smoking Cessation in COPD Patients: (Cost-)effectiveness of the SmokeStopTherapy and Validation of Abstinence. 2006, University of Twente, Enschede, the Netherlands.
33. Jacob, P., Byrd, G.D., Use of Gas Chromatographic and Mass Spectrometric Techniques for the Determination of Nicotine and its Metabolites. Gorrod, J.W., Jacob, P., (eds.) Analytical Determination of Nicotine and Related Compounds and Their Metabolites, 1999, Elsevier Science, Amsterdam, 191–224, 10.1016/B978-044450095-3/50007-3.
34. Jarvis, M.J., Tunstall-Pedoe, H., Feyerabend, C., Vesey, C., Saloojee, Y., Comparison of tests used to distinguish smokers from nonsmokers. Am. J. Public Health 77:11 (1987), 1435–1438, 10.2105/AJPH.77.11.1435.
35. Sepkovic, D.W., Haley, N.J., Hoffmann, D., Elimination from the body of tobacco products by smokers and passive smokers. J. Am. Med. Assoc., 256(7), 1986, 863, 10.1001/jama.1986.03380070069012.
36. Benowitz, N.L., Jacob, P., Ahijevych, K., Jarvis, M.J., Hall, S., LeHouezec, J., Velicer, W.F., Biochemical verification of tobacco use and cessation. Nicotine Tob. Res. 4:2 (2002), 149–159, 10.1080/14622200210123581.
37. Welsch, S.K., Smith, S.S., Wetter, D.W., Jorenby, D.E., Fiore, M.C., Baker, T.B., Development and validation of the Wisconsin smoking withdrawal scale. Exp. Clin. Psychopharmacol. 7:4 (1999), 354–361, 10.1037/1064-1297.7.4.354.
38. Zigmond, A.S., Snaith, R.P., The hospital anxiety and depression scale. Acta psychiatr. Scand. 67:6 (1983), 361–370, 10.1111/j.1600-0447.1983.tb09716.x.
39. Brown, K.W., Ryan, R.M., The benefits of being present: mindfulness and its role in psychological well-being. J. personal. Soc. Psychol. 84 (2003), 822–848, 10.1037/0022-3514.84.4.822.
40. Van der Molen, T., Willemse, B.W., Schokker, S., ten Hacken, N.H., Postma, D.S., Juniper, E.F., Development, validity and responsiveness of the clinical COPD questionnaire. Health Qual. Life Outcomes, 1, 2003, 13, 10.1186/1477-7525-1-13.
41. EuroQoL Group, EuroQoL: a new facility for the measurement of heath-related quality of life. Health Policy 16:3 (1990), 199–208, 10.1016/0168-8510(90)90421-9.
42. Brooks, R., Group, E., EuroQol: the current state of play. Health Policy, 37(1), 1996, 5372, 10.1016/0168-8510(96)00822-6.
43. Adda, J., Cornaglia, F., Taxes, cigarette consumption, and smoking intensity. Am. Econ. Rev. 96:4 (2006), 1013–1028, 10.1257/aer.103.7.3102.
44. Mudde, A.N., Willemsen, M.C., Kremers, S., De Vries, H., Meetinstrumenten voor onderzoek naar roken en stoppen met roken (rev.) [Measurements for research on smoking and smoking cessation]. 2006, Dutch Expertise Centre on Tobacco Control (STIVORO), The Hague.
45. Vestbo, J., Hurd, S.S., Agusti, A.G., Jones, P.W., Vogelmeier, C., Anzueto, A., Rodriguez-Roisin, R., Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease GOLD executive summary. Am. J. Resp. Crit. Care 187:4 (2013), 347–365, 10.1164/rccm.201204-0596PP.
46. Zigmond, A.S., Snaith, R.P., The hospital anxiety and depression scale. Acta psychiatr. Scand. 67:6 (1983), 361–370, 10.1111/j.1600-0447.1983.tb09716.x.
47. Christenhusz, L., Pieterse, M., Seydel, E., van der Palen, J., Prospective determinants of smoking cessation in COPD patients within a high intensity or a brief counseling intervention. Patient Educ. Couns. 66:2 (2007), 162–166, 10.1016/j.pec.2006.11.006.
48. Hedeker, D., Mermelstein, R.J., Demirtas, H., Analysis of binary outcomes with missing data: missing=smoking, last observation carried forward, and a little multiple imputation. Addiction 102:10 (2007), 1564–1573, 10.1111/j.1360-0443.2007.01946.x.
49. Blankers, M., Smit, E.S., van der Pol, P., de Vries, H., Hoving, C., van Laar, M., The missing=smoking assumption: a fallacy in internet-based smoking cessation trials?. Nicotine Tob. Res. 18:1 (2015), 25–33, 10.1093/ntr/ntv055.
50. Hartmann-Boyce, J., Lancaster, T.F.S.L., Print-based self-help interventions for smoking cessation. Cochrane Db Syst. Rev., 6, 2014, 10.1002/14651858.CD001118.pub3.
51. Lancaster, T., Stead, L.F., Self-help interventions for smoking cessation. Cochrane Db Syst. Rev., 3, 2005, 10.1002/14651858.CD001118.pub2.
52. Monninkhof, E., Van der Valk, P., Van der Palen, J., Mulder, H., Pieterse, M., Van Herwaarden, C., Zielhuis, G., The effect of a minimal contact smoking cessation programme in out-patients with chronic obstructive pulmonary disease: a pre-post-test study. Patient Educ. Couns. 52:3 (2004), 231–236, 10.1016/S0738-3991(03)00096-X.
53. Simmons, M.S., Connett, J.E., Nides, M.A., Lindgren, P.G., Kleerup, E.C., Murray, R.P., Tashkin, D.P., Smoking reduction and the rate of decline in FEV(1): results from the Lung Health Study. Eur. Respir. J. 25:6 (2005), 1011–1017, 10.1183/09031936.05.00086804.
54. Tan, S.S., Bouwmans, C.A., Rutten, F.F., Hakkaart-van Roijen, L., Update of the dutch manual for costing in economic evaluations. Int. J. Technol. Assess. Health Care 28:2 (2012), 152–158, 10.1017/S0266462312000062.